Several minimally invasive injectable modalities are safe and effective for the management of hair loss in adults with androgenetic alopecia.

Those who receive the COVID-19 vaccine during pregnancy are less likely to be hospitalized for COVID-19; however, vaccine uptake in this population is suboptimal.

Consensus recommendations have been established for pediatric mycosis fungoides, including additional clinical severity and outcome measures.

Extreme temperature-related deaths are projected to increase considerably by the mid-21st century in the contiguous United States.

The United States government is offering another round of free COVID-19 tests, which will be available by the end of September.

Fructose, carbonated soft drinks, and free sugar consumption may be linked to asthma, allergic rhinitis, and food allergies in children.

The aTIV vaccine provides better protection against influenza-related medical encounters than the HD-TIV vaccine in high-risk older adults.

Topline results were announced from a trial evaluating dapirolizumab pegol in patients with moderate to severe systemic lupus erythematosus.

Policy interventions to mitigate heat-related illness are needed based on the relationship between high HVI and severe stroke.

Prostaglandin analogues and phosphodiesterase inhibitors, either alone or as add-on therapy, are effective treatments for vitiligo repigmentation.

Treatment with baloxavir marboxil significantly reduced the risk of onward transmission of influenza within households.

Topline results were announced from a phase 3 trial evaluating rocatinlimab for the treatment of moderate to severe atopic dermatitis.